Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
Transfusion of blood components such as platelets, frozen plasma, and cryoprecipitate is a common practice in the neonatal intensive care unit. Although it is intuitive that these components would be transfused in the context of bleeding, their use in neonatology has often been on a prophylactic basis. Due to a lack of consensus guidelines regarding indications for transfusion, however, the neonatologist is left to his/her opinion as to when to transfuse. This article seeks to review the available evidence regarding the use of platelets, frozen plasma, and cryoprecipitate in neonates, as well as the risks associated with the administration of these products.
Poterjoy
Brandon S
BS
Division of Neonatal/Perinatal Medicine, Drexel University College of Medicine, St. Christopher's Hospital for Children, Philadelphia, PA, USA.
Josephson
Cassandra D
CD
D016913:Blood Component Transfusion / Q000379:methods*; D005169:Factor VIII / Q000008:administration & dosage; D005340:Fibrinogen / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn / Q000097:blood*; D015931:Intensive Care, Neonatal / Q000379:methods*; D010949:Plasma; D017713:Platelet Transfusion / Q000379:methods; D017410:Practice Guidelines as Topic
C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen